0001225208-14-006514.txt : 20140226
0001225208-14-006514.hdr.sgml : 20140226
20140226205138
ACCESSION NUMBER: 0001225208-14-006514
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140224
FILED AS OF DATE: 20140226
DATE AS OF CHANGE: 20140226
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP
CENTRAL INDEX KEY: 0000885725
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042695240
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE BOSTON SCIENTIFIC PL
CITY: NATICK
STATE: MA
ZIP: 01760-1537
BUSINESS PHONE: 508-650-8000
MAIL ADDRESS:
STREET 1: ONE BOSTON SCIENTIFIC PL
CITY: NATICK
STATE: MA
ZIP: 01760-1537
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dawkins Keith D
CENTRAL INDEX KEY: 0001492253
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11083
FILM NUMBER: 14646491
MAIL ADDRESS:
STREET 1: BOSTON SCIENTIFIC CORPORATION
STREET 2: ONE BOSTON SCIENTIFIC PLACE
CITY: NATICK
STATE: MA
ZIP: 01760
4
1
doc4.xml
X0306
4
2014-02-24
0000885725
BOSTON SCIENTIFIC CORP
BSX
0001492253
Dawkins Keith D
ONE BOSTON SCIENTIFIC PLACE
NATICK
MA
01760-1537
1
EVP, Global Chief Med. Off.
Common Stock
2014-02-24
4
A
0
36441.0000
0.0000
A
120398.0000
D
Common Stock
2014-02-24
4
M
0
2408.0000
0.0000
A
122806.0000
D
Common Stock
2014-02-24
4
F
0
12633.0000
13.0800
D
110173.0000
D
Deferred Stock Units
2014-02-24
4
M
0
2408.0000
0.0000
D
Common Stock
2408.0000
68789.0000
D
Deferred Stock Units
2014-02-24
4
A
0
11467.0000
0.0000
A
2019-02-24
Common Stock
11467.0000
11467.0000
D
Performance Share Units
2014-02-24
4
A
0
24011.0000
0.0000
A
2015-12-31
2015-12-31
Common Stock
24011.0000
24011.0000
D
Stock Option (Right to Buy)
13.0800
2014-02-24
4
A
0
27322.0000
0.0000
A
2024-02-24
Common Stock
27322.0000
27322.0000
D
On February 28, 2011, the reporting person was awarded a target number of performance share units under the Company's 2011 Total Shareholder Return Performance Share Program, the actual number of which to be earned by the reporting person was based on the Company's total shareholder return performance percentile relative to that of the other companies in the S&P 500 Healthcare Index over the three annual performance cycles comprising the three-year period ended December 31, 2013 and was subject to the completion of the concurrent three-year individual service period. On February 24, 2014, the number of the target performance share units as to which the performance criteria had been satisfied was determined and the individual service period was satisfied.
Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 24, 2010, the first anniversary of the date of grant.
Reflects multiple DSU awards with independent vesting schedules.
Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.
Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock.
On February 28, 2013, the reporting person was awarded a target number of performance share units under the Company's 2013 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2013 adjusted free cash flow measured against its 2013 financial plan over the one-year performance period ending December 31, 2013 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 24, 2014, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole on December 31, 2015 upon the completion of the individual service period.
Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.
/s/ Lee G. Giguere, Attorney-in-Fact
2014-02-26